Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,698.40
(
1.00%
)
US TECH 100
23,995.20
(
1.04%
)
Dow Jones
46,919.70
(
0.78%
)
Brent Oil
99.53
(
-1.68%
)
Bitcoin
74,355.00
(
2.12%
)
News Focus
News Focus
Post# of 257244
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122787
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 67950

Wednesday, 10/29/2008 9:15:36 PM

Wednesday, October 29, 2008 9:15:36 PM

Post# of 257244
Funny… I was just mulling whether to add GNLB's NS5A inhibitor to my post on “HCV Most Likely to Succeed” because Kurt Graves mentioned NS5A as one of the mechanisms VRTX was interested in combining with Telaprevir.

I guess we now know why he said that.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now